Elisabeth Rosenthal

Author's posts

How Your In-Network Health Coverage Can Vanish Before You Know It

One of the most unfair aspects of medical insurance is this: Patients can change insurance only during end-of-year enrollment periods or at the time of “qualifying life events.” But insurers’ contracts with doctors, hospitals, and pharmaceutical companies can change abruptly at any time.

GoFundMe Has Become a Health Care Utility

Resorting to crowdfunding to pay medical bills has become so routine, in some cases health professionals recommend it.

The FTC Is Attacking Drugmakers’ ‘Patent Thickets’

It’s a big job clearing out so-called “patent thickets” drugmakers create to keep their products’ prices high. But the Federal Trade Commission is giving it a shot.

Ouch. That ‘Free’ Annual Checkup Might Cost You. Here’s Why.

The designers of the Affordable Care Act might have assumed that they spelled out with sufficient clarity that millions of Americans would no longer have to pay for certain types of preventive care. But they didn’t reckon with America’s ever-creative medical billing juggernaut.

From Hospital to Hospitality: Spin Doctors Brand Getting Sick as an Adventure. It’s Not.

At $1,000 a night for a private room, medical centers are offering fancy food and casting health care as a “journey.” Instead of creature comforts, how about helping us feel better?

A New Era of Vaccines Leaves Old Questions About Prices Unanswered

The CDC’s RSV vaccination recommendations beg the question: How much should an immunization that will possibly be given to millions of Americans cost to be truly valuable?

The Shrinking Number of Primary Care Physicians Is Reaching a Tipping Point

The declining share of U.S. doctors in adult primary care is about 25% — a point beyond which many Americans won’t be able to find a family doctor at all.

A Peek at Big Pharma’s Playbook That Leaves Many Americans Unable to Afford Their Drugs

Brand-name drug prices in the U.S. — more than three times the price in other developed countries — are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?

Your Exorbitant Medical Bill, Brought to You by the Latest Hospital Merger

After decades of unchecked mergers, health care is the land of giants, with huge medical systems monopolizing care in many cities, states, and even whole regions of the country. This decreases patient choice, impedes innovation, erodes quality of care, and raises prices. And federal regulators have been slow to act.

An AI Chatbot May Be Your Next Therapist. Will It Actually Help Your Mental Health?

Given a dire shortage of human behavioral health providers in the U.S., it may prove tempting for insurers to offer up apps and chatbots to meet the federal mental health parity requirement. But artificial intelligence, by definition fake, can’t master the empathic flow between patient and doctor that’s central to therapy.